176 related articles for article (PubMed ID: 34876813)
1. Assessment to the Antifungal Effects in vitro and the Ocular Pharmacokinetics of Solid-Lipid Nanoparticle in Rabbits.
Liang Z; Zhang Z; Yang J; Lu P; Zhou T; Li J; Zhang J
Int J Nanomedicine; 2021; 16():7847-7857. PubMed ID: 34876813
[TBL] [Abstract][Full Text] [Related]
2. The effect of charges on the corneal penetration of solid lipid nanoparticles loaded Econazole after topical administration in rabbits.
Liang Z; Zhang Z; Lu P; Yang J; Han L; Liu S; Zhou T; Li J; Zhang J
Eur J Pharm Sci; 2023 Aug; 187():106494. PubMed ID: 37315870
[TBL] [Abstract][Full Text] [Related]
3. Natamycin solid lipid nanoparticles - sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization.
Khames A; Khaleel MA; El-Badawy MF; El-Nezhawy AOH
Int J Nanomedicine; 2019; 14():2515-2531. PubMed ID: 31040672
[TBL] [Abstract][Full Text] [Related]
4. Fabrication of a drug delivery system that enhances antifungal drug corneal penetration.
Li J; Li Z; Liang Z; Han L; Feng H; He S; Zhang J
Drug Deliv; 2018 Nov; 25(1):938-949. PubMed ID: 29658325
[TBL] [Abstract][Full Text] [Related]
5. Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy.
Fu T; Yi J; Lv S; Zhang B
J Liposome Res; 2017 Sep; 27(3):228-233. PubMed ID: 27601177
[TBL] [Abstract][Full Text] [Related]
6. Thermosensitive Tri-Block Polymer Nanoparticle-Hydrogel Composites as Payloads of Natamycin for Antifungal Therapy Against
Sha X; Chan L; Fan X; Guo P; Chen T; Liu L; Zhong J
Int J Nanomedicine; 2022; 17():1463-1478. PubMed ID: 35378880
[TBL] [Abstract][Full Text] [Related]
7. Novel nanomicelle butenafine formulation for ocular drug delivery against fungal keratitis: In Vitro and In Vivo study.
Lu P; Liang Z; Zhang Z; Yang J; Song F; Zhou T; Li J; Zhang J
Eur J Pharm Sci; 2024 Jan; 192():106629. PubMed ID: 37918544
[TBL] [Abstract][Full Text] [Related]
8. Miconazole-loaded solid lipid nanoparticles: formulation and evaluation of a novel formula with high bioavailability and antifungal activity.
Aljaeid BM; Hosny KM
Int J Nanomedicine; 2016; 11():441-7. PubMed ID: 26869787
[TBL] [Abstract][Full Text] [Related]
9. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir.
Seyfoddin A; Al-Kassas R
Drug Dev Ind Pharm; 2013 Apr; 39(4):508-19. PubMed ID: 22424312
[TBL] [Abstract][Full Text] [Related]
10. Formulation and Pathohistological Study of Mizolastine-Solid Lipid Nanoparticles-Loaded Ocular Hydrogels.
El-Emam GA; Girgis GNS; Hamed MF; El-Azeem Soliman OA; Abd El Gawad AEGH
Int J Nanomedicine; 2021; 16():7775-7799. PubMed ID: 34853513
[TBL] [Abstract][Full Text] [Related]
11. Lipid-polyethylene glycol based nano-ocular formulation of ketoconazole.
Kakkar S; Karuppayil SM; Raut JS; Giansanti F; Papucci L; Schiavone N; Kaur IP
Int J Pharm; 2015 Nov; 495(1):276-289. PubMed ID: 26325312
[TBL] [Abstract][Full Text] [Related]
12. Lipo-PEG nano-ocular formulation successfully encapsulates hydrophilic fluconazole and traverses corneal and non-corneal path to reach posterior eye segment.
Kakkar S; Singh M; Mohan Karuppayil S; Raut JS; Giansanti F; Papucci L; Schiavone N; Nag TC; Gao N; Yu FX; Ramzan M; Kaur IP
J Drug Target; 2021 Jul; 29(6):631-650. PubMed ID: 33410357
[TBL] [Abstract][Full Text] [Related]
13. Natamycin niosomes as a promising ocular nanosized delivery system with ketorolac tromethamine for dual effects for treatment of candida rabbit keratitis; in vitro/in vivo and histopathological studies.
El-Nabarawi MA; Abd El Rehem RT; Teaima M; Abary M; El-Mofty HM; Khafagy MM; Lotfy NM; Salah M
Drug Dev Ind Pharm; 2019 Jun; 45(6):922-936. PubMed ID: 30744431
[TBL] [Abstract][Full Text] [Related]
14. Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues.
Balguri SP; Adelli GR; Majumdar S
Eur J Pharm Biopharm; 2016 Dec; 109():224-235. PubMed ID: 27793755
[TBL] [Abstract][Full Text] [Related]
15. Fabrication and evaluation of lipid nanoparticulates for ocular delivery of a COX-2 inhibitor.
Sharma AK; Sahoo PK; Majumdar DK; Sharma N; Sharma RK; Kumar A
Drug Deliv; 2016 Nov; 23(9):3364-3373. PubMed ID: 27128623
[TBL] [Abstract][Full Text] [Related]
16. Colloidal lipid nanodispersion enriched hydrogel of antifungal agent for management of fungal infections: Comparative in-vitro, ex-vivo and in-vivo evaluation for oral and topical application.
Dudhipala N; Ali Youssef AA; Banala N
Chem Phys Lipids; 2020 Nov; 233():104981. PubMed ID: 33031802
[TBL] [Abstract][Full Text] [Related]
17. Amelioration of ketoconazole in lipid nanoparticles for enhanced antifungal activity and bioavailability through oral administration for management of fungal infections.
Dudhipala N; Ay AA
Chem Phys Lipids; 2020 Oct; 232():104953. PubMed ID: 32814084
[TBL] [Abstract][Full Text] [Related]
18. Microwave-assisted microemulsion technique for production of miconazole nitrate- and econazole nitrate-loaded solid lipid nanoparticles.
Shah RM; Eldridge DS; Palombo EA; Harding IH
Eur J Pharm Biopharm; 2017 Aug; 117():141-150. PubMed ID: 28411057
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of itraconazole-loaded solid lipid nanoparticles for ocular delivery.
Mohanty B; Majumdar DK; Mishra SK; Panda AK; Patnaik S
Pharm Dev Technol; 2015 Jun; 20(4):458-64. PubMed ID: 24490828
[TBL] [Abstract][Full Text] [Related]
20. Solid lipid nanoparticles for ocular delivery of isoniazid: evaluation, proof of concept and in vivo safety & kinetics.
Singh M; Guzman-Aranguez A; Hussain A; Srinivas CS; Kaur IP
Nanomedicine (Lond); 2019 Feb; 14(4):465-491. PubMed ID: 30694726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
